Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sy

Showing results (321-330 of 341) with videos related to

Pageof 35
Sort By:
Human Vaccines & Immunotherapeutics|December 8, 2025
Effectiveness and safety of the recombinant zoster vaccine in adults aged ≥50 years with inflammatory bowel diseaseHung Fu Tseng, Lina S Sy, Emily Rayens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
Adjuvanted recombinant zoster vaccine is effective against herpes zoster ophthalmicus, and is associated with lower risk of acute myocardial infarction and stroke in adults aged ≥50 yearsEmily Rayens, Lina S Sy, Lei Qian, et al.
JAMA Network Open|June 6, 2024
COVID-19 Vaccination Coverage and Factors Associated With Vaccine Uptake Among People With HIVRulin C Hechter, Lei Qian, In-Lu Amy Liu, et al.
Nature Communications|January 12, 2023
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5Hung Fu Tseng, Bradley K Ackerson, Katia J Bruxvoort, et al.
JAMA Network Open|August 12, 2022
Health Care Utilization in the 6 Months Following SARS-CoV-2 InfectionSara Y Tartof, Deborah E Malden, In-Lu Amy Liu, et al.
Vaccine|February 22, 2024
Mortality risk after COVID-19 vaccination: A self-controlled case series studyStanley Xu, Lina S Sy, Vennis Hong, et al.
Nature Communications|September 20, 2023
mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United StatesHung Fu Tseng, Bradley K Ackerson, Lina S Sy, et al.
Vaccine|June 18, 2022
Safety of tetanus, diphtheria, acellular pertussis (Tdap) vaccination during pregnancyHung Fu Tseng, Lina S Sy, Bradley K Ackerson, et al.
Infectious Diseases and Therapy|December 15, 2022
Investigating Tetanus, Diphtheria, Acellular Pertussis Vaccination During Pregnancy and Risk of Congenital AnomaliesAna Florea, Lina S Sy, Bradley K Ackerson, et al.
Open Forum Infectious Diseases|May 22, 2026
Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design AnalysisJennifer H Ku, Lei Qian, Lina S Sy, et al.
Pageof 35

Showing results (321-330 of 341) with videos related to

Sort By:
Pageof 35
Human Vaccines & Immunotherapeutics|December 8, 2025
Effectiveness and safety of the recombinant zoster vaccine in adults aged ≥50 years with inflammatory bowel diseaseHung Fu Tseng, Lina S Sy, Emily Rayens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
Adjuvanted recombinant zoster vaccine is effective against herpes zoster ophthalmicus, and is associated with lower risk of acute myocardial infarction and stroke in adults aged ≥50 yearsEmily Rayens, Lina S Sy, Lei Qian, et al.
JAMA Network Open|June 6, 2024
COVID-19 Vaccination Coverage and Factors Associated With Vaccine Uptake Among People With HIVRulin C Hechter, Lei Qian, In-Lu Amy Liu, et al.
Nature Communications|January 12, 2023
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5Hung Fu Tseng, Bradley K Ackerson, Katia J Bruxvoort, et al.
JAMA Network Open|August 12, 2022
Health Care Utilization in the 6 Months Following SARS-CoV-2 InfectionSara Y Tartof, Deborah E Malden, In-Lu Amy Liu, et al.
Vaccine|February 22, 2024
Mortality risk after COVID-19 vaccination: A self-controlled case series studyStanley Xu, Lina S Sy, Vennis Hong, et al.
Nature Communications|September 20, 2023
mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United StatesHung Fu Tseng, Bradley K Ackerson, Lina S Sy, et al.
Vaccine|June 18, 2022
Safety of tetanus, diphtheria, acellular pertussis (Tdap) vaccination during pregnancyHung Fu Tseng, Lina S Sy, Bradley K Ackerson, et al.
Infectious Diseases and Therapy|December 15, 2022
Investigating Tetanus, Diphtheria, Acellular Pertussis Vaccination During Pregnancy and Risk of Congenital AnomaliesAna Florea, Lina S Sy, Bradley K Ackerson, et al.
Open Forum Infectious Diseases|May 22, 2026
Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design AnalysisJennifer H Ku, Lei Qian, Lina S Sy, et al.
Pageof 35